The EU is rolling out new restrictions targeting Chinese medical device suppliers in public procurement, sparking fresh trade tensions. 🌍⚖️ The move, backed by EU member states, marks the first use of the bloc’s International Procurement Instrument (IPI), which allows limiting foreign bidders’ access to government contracts. Critics call it a 'protectionist pivot' that could strain China-EU economic ties.
China’s Ministry of Commerce swiftly opposed the measures, arguing they clash with the EU’s claims of 'openness and fairness.' The China Chamber of Commerce to the EU warned the decision adds 'new complexity' to trade relations. Meanwhile, Chinese firms have historically won EU contracts through competitive pricing, despite China not yet joining the WTO’s Government Procurement Agreement (GPA).
Here’s the twist: China applied for GPA membership in 2007 and has since expanded its market access offers. But negotiations stalled as existing members, including the EU, demand more concessions. While foreign companies can bid in China’s public tenders, the EU’s latest move raises questions about a level playing field. 🔄💡
Analysts say the clash reflects broader global trade uncertainties. Will this escalate into a tit-for-tat scenario? Stay tuned. 📈🔍
